TRAVIS SATTERFIELD: Open Payments
NPI 1750916359 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,269 in 115 payments from 20 companies in 2025. Trend: 2023 $1,560 · 2024 $2,238 · 2025 $2,269
Food & beverage: $2,269
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $507 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $285 |
| Janssen Biotech, Inc. | 17 | $253 |
| Aimmune Therapeutics, Inc. | 10 | $197 |
| Madrigal Pharmaceuticals | 8 | $167 |
| Lilly USA, LLC | 5 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $105 |
| Ipsen Biopharmaceuticals, Inc | 4 | $102 |
| GENZYME CORPORATION | 5 | $97 |
| Gilead Sciences, Inc. | 3 | $94 |
Products named: TREMFYA, LINZESS, ZENPEP, ENTYVIO, REZDIFFRA, RINVOQ, DUPIXENT, OMVOH.
Industry payments across FL — which companies pay providers there.
